Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials

The clinical efficacy of continuous subcutaneous insulin infusion (CSII) therapy combined with six classes of oral glucose-lowering drugs (GLDs) (TZDs/metformin/acarbose/GLP-1 receptor agonist/SGLT-2 inhibitor/DPP-4 inhibitor) was evaluated by a network meta-analysis to provide an evidence-based ref...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui, Yang, Aimin, Zhao, Shi, Chow, Elaine YK, Javanbakht, Mohammad, Li, Yinhui, Lin, Dandan, Xu, Lijuan, Zang, Deng, Wang, Kai, Ma, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412496/
https://www.ncbi.nlm.nih.gov/pubmed/36015100
http://dx.doi.org/10.3390/ph15080953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412496/
https://www.ncbi.nlm.nih.gov/pubmed/36015100
http://dx.doi.org/10.3390/ph15080953

Ejemplares similares